1. Garrido Lopez P. Treatment decisions and side effect management of new drugs (including immunotherapy) in lung cancer. Esmo 2018. https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/Treatment-decisions-and-side-effect-management-of-new-drugs-including-immunotherapy-in-lung-cancer-General-Discussion2.
2. Les chimiothérapies orales;Clere;Act Pharm,2018
3. Kaasa S. Best integration of supportive and palliative care in the continuum of care. Esmo 2018. https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/Highlights-of-the-Lancet-Oncology-commission-paper-Integration-of-oncology-and-palliative-care.
4. Integration of oncology and palliative care: a Lancet Oncology Commission;Kaasa;Lancet Oncol,2018
5. Järvinen M. The essential elements of safety standards for systemic cancer therapies. Esmo 2018. https://oncologypro.esmo.org/Meeting-Resources/ESMO-2018-Congress/EONS-session-The-essential-elements-of-safety-standards-for-systemic-cancer-therapies-The-patient-s-perspective.